MedTrace Logo

Preoxygenation Using THRIVE Versus Facemask in Parturients

NCT03772574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2022-05-24

Study results available
· View outcomes & findings →

Summary

This study aims to determine the duration for pre-oxygenation using THRIVE and facemask for parturients.

Conditions

  • Preoxygenation

Interventions

DEVICE

Facemask preoxygenation

Standard facemask preoxygenation

DEVICE

THRIVE preoxygenation

Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Anton Chau, MD MMSc · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-07-15
Completion
2020-04-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03772574 on ClinicalTrials.gov